Abstract:Inflammatory bowel disease (IBD) patients experience up to 6-fold increased risk of venous thromboembolism (VTE) compared to the general population, although the mechanistic basis for this increased risk remains poorly defined. We found that colitogenic CD4 T cells express tissue factor (TF) and promote rapid TF-dependent plasma thrombin generation in T cell-dependent calibrated automated thrombinography assays. Furthermore, we identified the presence of TF CD4 CD3 T cells in the colons of both mice with colitis and paediatric IBD patients during active disease. TF is typically expressed in an ‘encrypted’ state and requires decryption for optimal procoagulant activity. Notably, flow cytometric analysis demonstrated that activated CD4 T cells express significantly increased acid sphingomyelinase and protein disulphide isomerase, critical mediators for TF decryption, on their cell membrane compared to naïve T cells. The protein C (PC) pathway is an important regulator of TF-mediated thrombin generation. Pertinently, pre-clinical studies suggest an important role for diminished PC pathway activity in IBD pathophysiology. To understand how this process might be regulated, we performed meta-transcriptomic and gene expression analysis of IBD patient gut biopsy tissue, identifying dysregulated expression of genes involved in the regulation of coagulation, including PC ( and its receptor (EPCR; . Subsequent functional studies revealed that activated protein C (APC) signalling reduced colitogenic T cell generation and activity, potently impaired TF decryption and significantly reduced T cell-mediated thrombin generation and clot formation. These data identify TF-mediated colitogenic T cell thrombogenicity and demonstrate a new role for APC signalling in regulating T cell thrombo-inflammatory activity.

Regulation of tissue factor activity by interaction with the first PDZ domain of MAGI1

The Tiam1 Guanine Nucleotide Exchange Factor is Auto-Inhibited by Its Pleckstrin Homology Coiled-Coil Extension Domain.

TACE activation by MAPK-mediated regulation of cell surface dimerization and TIMP3 association.

P21-Activated Kinase-1 Signaling Regulates Transcription of Tissue Factor and Tissue Factor Pathway Inhibitor.

Phosphorylation-dependent recognition of diverse protein targets by the cryptic GK domain of MAGI MAGUKs

Tissue factor at the crossroad of coagulation and cell signaling

Regulation of Tissue Factor by CD44 Supports Coagulant Activity in Breast Tumor Cells

[Expression of Tissue Factor of Astrocytes and Its Signal Transductional Pathways].

Tissue factor pathway inhibitor – cofactor-dependent regulation of the initiation of coagulation

Tissue Factor and Tissue Factor Pathway Inhibitor in Coronary Atherosclerotic Plaque

Tissue Factor Noncoagulant Signaling: Mechanisms and Implications for Cell Migration and Apoptosis

11-16-2012 p 21-activated kinase-1 signaling regulates transcription of tissue factor and tissue factor pathway inhibitor

Monocyte Tissue Factor Expression: Lipopolysaccharide Induction and Roles in Pathological Activation of Coagulation

The Tissue Factor Pathway in Cancer: Overview and Role of Heparan Sulfate Proteoglycans

Mechanistic insight into GPCR-mediated activation of the microtubule-associated RhoA exchange factor GEF-H1

Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets

Tissue factor in atherosclerosis and atherothrombosis

Tissue factor (:Factor VIIa) in the heart and vasculature: More than an envelope

15-Deoxy-Δ12,14-Prostaglandin J2 Inhibits Tissue Factor Expression in Human Macrophages and Endothelial Cells: Evidence for ERK1/2 Signaling Pathway Blockade

Generation and Application of Active Recombinant Mouse Tissue Factor and Its Function-blocking Monoclonal Antibody

Tissue factor-dependent colitogenic CD4+ T cell thrombogenicity is regulated by activated protein C signalling